XENLETA Trademark

Trademark Overview

On Friday, March 8, 2019, a trademark application was filed for XENLETA with the United States Patent and Trademark Office. The USPTO has given the XENLETA trademark a serial number of 88332586. The federal status of this trademark filing is REGISTERED as of Tuesday, April 28, 2020. This trademark is owned by Nabriva Therapeutics US, Inc.. The XENLETA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating respiratory illnesses; antibiotics; pharmaceutical preparations for the treatment of pneumonia and bacterial infections
xenleta

General Information

Serial Number88332586
Word MarkXENLETA
Filing DateFriday, March 8, 2019
Status700 - REGISTERED
Status DateTuesday, April 28, 2020
Registration Number6043681
Registration DateTuesday, April 28, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating respiratory illnesses; antibiotics; pharmaceutical preparations for the treatment of pneumonia and bacterial infections
Translation of Words in MarkThe wording "XENLETA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 27, 2019
Primary Code005
First Use Anywhere DateSaturday, August 31, 2019
First Use In Commerce DateSaturday, August 31, 2019

Trademark Owner History

Party NameNabriva Therapeutics US, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFort Washington, PA 19034
Party NameNabriva Therapeutics US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406
Party NameNabriva Therapeutics US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406

Trademark Events

Event DateEvent Description
Thursday, May 16, 2019ASSIGNED TO EXAMINER
Tuesday, March 12, 2019NEW APPLICATION ENTERED
Wednesday, March 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 22, 2019NON-FINAL ACTION WRITTEN
Wednesday, May 22, 2019NON-FINAL ACTION E-MAILED
Wednesday, May 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 30, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 4, 2019ASSIGNED TO LIE
Wednesday, June 5, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 5, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 12, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 26, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 16, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 30, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 30, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 30, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 19, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, February 19, 2020USE AMENDMENT FILED
Wednesday, February 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 20, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 20, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 20, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, March 7, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, March 8, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, March 23, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 24, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 28, 2020REGISTERED-PRINCIPAL REGISTER
Friday, August 20, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, August 20, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 20, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 4, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 4, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 4, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 4, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 28, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

xenleta pharmaceutical preparations pneumonia infections treatment bacterial illnesses treating respiratory antibiotics